We also observed that the inflammatory genes downregulated in the glial cultures treated with the SGK1 inhibitor included components of the cyclic GMP‐AMP synthase (CGAS)‐stimulator of interferon response cGAMP interactor 1 genes (STING) pathway (Fig 3E and F), which has recently been identified as another critical pathogenic contributor to PD caused by Parkin and PINK1 mutations (Sliter et al, 2018). The gene discussed is SGK1; the disease is Parkinson disease.